Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-06-07
1993-07-27
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 81, 514 91, A61K 3702, C07K 506
Patent
active
052310841
ABSTRACT:
The invention relates to new comoounds having a cognition adjuvant action, to the use of ACE inhibitors as medicaments having a cognition adjuvant action, to agents containing them, and to the use thereof for the treatment and prophylaxis of cognitive dysfunctions.
REFERENCES:
patent: 4129571 (1978-12-01), Ondetti et al.
patent: 4344949 (1982-08-01), Hoefle et al.
patent: 4350704 (1982-09-01), Hoefle et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4374847 (1983-02-01), Gruenfeld
patent: 4374847 (1983-02-01), Gruenfeld
patent: 4454292 (1984-06-01), Kim et al.
patent: 4470972 (1981-09-01), Gold et al.
patent: 4508729 (1985-04-01), Vincent et al.
patent: 4525301 (1985-06-01), Henning et al.
patent: 4558065 (1985-12-01), Urbach et al.
patent: 4562202 (1985-12-01), Urbach et al.
patent: 4587258 (1986-05-01), Gold et al.
patent: 4588064 (1985-12-01), Teetz et al.
patent: 4591598 (1986-05-01), Urbach et al.
patent: 4614805 (1986-09-01), Urbach et al.
patent: 4620012 (1986-10-01), Henning et al.
patent: 4624962 (1986-11-01), Henning et al.
patent: 4659838 (1987-04-01), Lerch
patent: 4668796 (1987-05-01), Geiger et al.
patent: 4668797 (1987-05-01), Urbach et al.
patent: 4684662 (1987-08-01), Henning et al.
patent: 4691022 (1987-09-01), Henning et al.
patent: 4714708 (1987-12-01), Urbach et al.
patent: 4727160 (1988-02-01), Teetz et al.
patent: 4808573 (1989-02-01), Gold et al.
patent: 4818749 (1989-04-01), Gold et al.
patent: 4822894 (1989-04-01), Geiger et al.
patent: 4831157 (1989-05-01), Gold et al.
patent: 4849524 (1989-07-01), Henning et al.
patent: 4868307 (1989-09-01), Barton et al.
patent: 4886827 (1989-12-01), Urbach et al.
patent: 4931460 (1990-06-01), Sudilovsky et al.
patent: 5015633 (1991-05-01), Sudilovsky
U. Schindler et al., Nootropic Drugs: Animal Models for Studying Effects on Cognition, Drug Development Research 4:567-576 (1984).
R. T. Bartus, et al. Logical Principles for the Development of Animal Models of Age-Related Memory Impairments, Assessment in Geriafric Psychopharmacology, published by Mark Pauley Associates, Inc. 88 Main Street, New Cannan, Connecticut, USA, Dec. 1983, pp. 263-299.
G. Pepeu, The Relationship Between the Behavioral Effects of Cognition-Enhancing Drug and Brain Acetylcholine, Pharmacopsychiat, 22, 116-119, (1989).
Brunner et al., J. Cardiovasc Pharmacol. vol. 7 (Suppl. 1), pp. 2-11 (1985).
Leonard et al., J. Am. Chem. Soc., 77, 439 (1955).
Leonard et al., J. Am. Chem. Soc., 78, 3457 (1956).
Leonard et al., J. Am. Chem. Soc., 78, 3463 (1956).
Leonard et al., J. Am. Chem. Soc., 81, 5627 (1959).
Koelsch et al., J. Org. Chem., 26, 1104 (1961).
Griot et al., Helv. Chim. Acta, 42, 121 (1959).
Bonnett et al., J. Chem. Soc., 2087 (1959).
Battersby et al., J. Chem. Soc., 4333 (1958).
Rosenblatt et al., The Chemistry Of Functional Groups. Supplement F: The Chemistry of Amino, Nitroso and Nitro Compounds And Their Derivatives. Part II, S. Patai, ed., Wiley & Sons: New York 1982, pp. 1100-1104.
L. W. Haynes, Enamines, A. G. Cook, ed., Marcel Decker, Inc.: 1969, pp. 68-79, 261-269, 413.
Fieser & Fieser, Reagents For Organic Synthesis, vol. 1, pp. 644-651 (1967).
Boehme et al., Iminium Salts in Organic Chemistry, Part I (E. C. Taylor, ed.), Wiley & Sons: New York, 1976, p. 143.
S. Dayagi et al., The Chemistry of Functional Groups. The Chemistry Of The Carbon-Nitrogen Double Bond, S. Patai, ed., Wiley & Sons: New York, 1970, p. 119.
W. Greenlee et al., J. Med. Chem., 28, 434-442 (1985).
K. Ogawa et al., J. Chem. Soc., Perkin Trans. I, 3031-3035 (1982).
R. Bacon and D. Stewart, J. Chem. Soc. (C), 1384-1387 (1966).
R. Bacon et al., J. Chem. Soc. (C), 1388-1389 (1966).
Patchett et al., Nature, 288, 280-283 (1980).
Booth et al., Chemistry and Industry, 466-467 (1956).
Booth et al., J. Chem. Soc., Part I, 1050-1054 (1959).
Murakoshi et al., Chemical Abstracts, 61, 9465(e) (1964).
Cushman et al., Fed. Proc., 38 (13), 2778-2782 (1979).
Houben-Weyl, Methoden der Organischen Chemie, 7(2b), 1403-1404 (1976).
Katritskaya, Dzh. Lagorskaya Khimia Geterosikl. Soedin., Moskow 1963, pp. 155-158.
Anderson, Jr. et al., J. Org. Chem., 43(1), 54-57 (1978).
Bertho et al., Synthesen In Der 2-Azabicyclo[0.3.3]-octan-Reihe, Chemische Berichte, 92(7), 2218-2235 (1959).
Farkas et al., J. Org. Chem., 22, 1261-1263 (1957).
Taylor et al., J. Org. Chem., 38(16), 2817-2821 (1973).
Taylor et al., Heterocycles, 25, 343-345 (1987).
English language translation of Mitzlaff et al., Liebig's Ann. Chem., 1713-1733 (1978).
Chem. Berichte 86: 1524-1528 (1953).
Quarterly Reviews 25: 323-341 (1971).
Chem. Abst. 49/1955/3009c.
Bolis, "Renin Inhibitors" J. Med. Chem. 30, 1729-1737 (1987).
Haber, "Renin Inhibitors", J. Cardiovascular Pharm. S54-S58 (1987).
Plattner, "Renin Inhibitors", 2277-288 (1988) 31.
Denkervalte, Progress in Drug Research, vol. 10 pp. 510-512.
Burger, "Medicinal Chemistry" 2nd edition, 1960 Interscience Publishers pp. 565-601.
Henning Rainer
Hock Franz
Lerch Ulrich
Nickel Wolf-Ulrich
Ruger Wolfgang
Hoechst Aktiengesellschaft
Lee Lester L.
LandOfFree
Compounds having a cognition adjuvant action, agents containing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having a cognition adjuvant action, agents containing , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having a cognition adjuvant action, agents containing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2342348